Neos Investment Management LLC Celldex Therapeutics, Inc. Transaction History
Neos Investment Management LLC
- $4.25 Trillion
- Q4 2024
A detailed history of Neos Investment Management LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 20,261 shares of CLDX stock, worth $403,801. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,261
Previous 26,592
23.81%
Holding current value
$403,801
Previous $904 Million
43.35%
% of portfolio
0.01%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
60.7MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$101 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$93.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$77.4 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$74.8 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$70.9 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $932M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...